Kraeher Aleksandra entered the industry of Endocrinologists in 2007 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621111, which describes it as a Endocrinologists. For further clarification, the SIC classifies this business under the code 8011 and described it as a Endocrinologists. The business provides service to the B2C market.
To acquire more information, please contact Aleksandra Kraeher by calling (561) 626-9041 during business hours. You can also write to the business’ Single Location at 4600 North Mlitary Trail # 21, West Palm Beach, Florida FL 33409. You can also visit the company’s website at endo-diabetes.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Kraeher Aleksandra |
| Representative: | Aleksandra Kraeher |
| Place of Business: | 4600 North Mlitary Trail # 21, West Palm Beach, FL 33409 |
| Contact Number: | (561) 626-9041 |
| Website: | endo-diabetes.com |
| Type of Service: | Endocrinologists |
| SIC Number: | 8011 |
| NAICS Number: | 621111 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 2007 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Kraeher Aleksandra is a company operating from Palm Beach, Florida providing professional Endocrinologists and relevant B2C variables. It was founded in 2007 and registered with the SIC code 8011 as Endocrinologists, and with the NAICS code 621111 as Endocrinologists.
With a current employee count of 1 to 4, Kraeher Aleksandra has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Aleksandra Kraeher at (561) 626-9041 for related queries, or to locate its Single Location using the coordinates 26.7479,-80.109106.
The Single Location can also be found at the street address 4600 North Mlitary Trail # 21 in West Palm Beach, Florida 33409 and can be engaged online through the company website at endo-diabetes.com, the company Twitter , and Facebook page .